Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual erbium 1550 nm and thulium 1927 nm laser vs dual laser plus topical PDRN for melasma
TCTR20260210011Phase 2Active, not recruiting
- Sponsor
- Chulabhorn International College of Medicine
- Start
- Jan 2026
- Modality
- Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of polideoxirybonucleotide in melasma, sponsored by Chulabhorn International College of Medicine. Started Jan 2026; status: active, not recruiting.
02
Drugs
polideoxirybonucleotide
03
Conditions
melasma
Beyond the preview
Go deeper on TCTR20260210011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260210011.